Michael Sousa brings over 25 years of comprehensive quality leadership to LandmarkBio, specializing in quality assurance, control, systems, and robust supplier / partner oversight. His extensive career spans recombinant proteins and cutting-edge cell and gene therapies, supporting programs from early clinical development to commercialization. Michael excels at establishing, scaling, and optimizing quality systems within fast-paced, highly complex, and tightly regulated environments.
Michael firmly believes quality management is a strategic asset that drives operational excellence, fosters continuous improvement, ensures patient safety, and ultimately transforms an organization into a more resilient and reputable leader in the industry. His servant leadership style, honed at Amgen and uniQure, empowers teams and builds adaptable quality infrastructures. Michael is instrumental in cultivating a strong compliance culture, skillfully navigating the unique quality challenges of innovation in advanced modalities. He holds a B.S. in Biology from the University of Massachusetts – Dartmouth.